9 research outputs found
A colorimetric strategy based on dynamic chemistry for direct detection of Trypanosomatid species
Leishmaniasis and Chagas disease are endemic in many countries, and re-emerging in the developed
countries. A rapid and accurate diagnosis is important for early treatment for reducing the duration
of infection as well as for preventing further potential health complications. In this work, we have
developed a novel colorimetric molecular assay that integrates nucleic acid analysis by dynamic
chemistry (ChemNAT) with reverse dot-blot hybridization in an array format for a rapid and easy
discrimination of Leishmania major and Trypanosoma cruzi. The assay consists of a singleplex PCR
step that amplifies a highly homologous DNA sequence which encodes for the RNA component of the
large ribosome subunit. The amplicons of the two different parasites differ between them by single
nucleotide variations, known as “Single Nucleotide Fingerprint” (SNF) markers. The SNF markers can
be easily identified by naked eye using a novel micro Spin-Tube device "Spin-Tube", as each of them
creates a specific spot pattern. Moreover, the direct use of ribosomal RNA without requiring the PCR
pre-amplification step is also feasible, further increasing the simplicity of the assay. The molecular
assay delivers sensitivity capable of identifying up to 8.7 copies per μL with single mismatch specificity.
The Spin-Tube thus represents an innovative solution providing benefits in terms of time, cost, and
simplicity, all of which are crucial for the diagnosis of infectious disease in developing countries.This research work has received funding from Junta de Andalucía, Consejería de Economía e Innovación (project
number 2012-BIO1778), the Spanish Ministerio de Economía y Competitividad (Grants CTQ2012-34778,
BIO2016-80519-R, FPI Grant BES-2013- 063020). This research was partially supported by the 7th European
Community Framework Program (FP7-PEOPLE-2012-CIG-Project Number 322276)
Influence of the chirality of short peptide supramolecular hydrogels in protein crystallogenesis
For the first time the influence of the chirality of the gel fibers in protein crystallogenesis has been studied. Enantiomeric hydrogels 1 and 2 were tested with model proteins lysozyme and glucose isomerase and a formamidase from B. cereus.
Crystallization behaviour and crystal quality of these proteins in both hydrogels are presented and compared.MICINN (Spain) projects BIO2010-16800 (JAG), CTQ-2011.22455 (LAC & JMC), CTQ2012-34778 (JJDM
& ALG), “Factoría Española de Cristalización” Consolider-Ingenio 2010 (JAG & MCM) and EDRF Funds (JAG, LAC & JMC), P12-FQM-2721 (LAC) Junta de Andalucía.MINECO,Project No. FIS2013-41821-R
Development of a nanotechnology-based approach for capturing and detecting nucleic acids by using flow cytometry.
Nucleic acid-based molecular diagnosis has gained special importance for the detection and early diagnosis of genetic diseases as well as for the control of infectious disease outbreaks. The development of systems that allow for the detection and analysis of nucleic acids in a low-cost and easy-to-use way is of great importance. In this context, we present a combination of a nanotechnology-based approach with the already validated dynamic chemical labeling (DCL) technology, capable of reading nucleic acids with single-base resolution. This system allows for the detection of biotinylated molecular products followed by simple detection using a standard flow cytometer, a widely used platform in clinical and molecular laboratories, and therefore, is easy to implement. This proof-of-concept assay has been developed to detect mutations in KRAS codon 12, as these mutations are highly important in cancer development and cancer treatments
Serum Galanin Levels in Young Healthy Lean and Obese Non-Diabetic Men during an Oral Glucose Tolerance Test.
Galanin (GAL) is a neuropeptide involved in the homeostasis of energy metabolism. The objective of this study was to investigate the serum levels of GAL during an oral glucose tolerance test (OGTT) in lean and obese young men. This cross-sectional study included 30 obese non-diabetic young men (median 22 years; mean BMI 37 kg/m(2)) and 30 healthy lean men (median 23 years; mean BMI 22 kg/m(2)). Serum GAL was determined during OGTT. The results of this study include that serum GAL levels showed a reduction during OGTT compared with basal levels in the lean subjects group. Conversely, serum GAL levels increased significantly during OGTT in obese subjects. Serum GAL levels were also higher in obese non-diabetic men compared with lean subjects during fasting and in every period of the OGTT (p
Amplification-free profiling of microRNA-122 biomarker in DILI patient serums, using the Luminex MAGPIX system
Dynamic chemical labelling is a single-base specific method to enable detection and quantification of micro-Ribonucleic Acids in biological fluids without extraction and pre-amplification. In this study, dynamic chemical labelling was combined with the Luminex MAGPIX system to profile levels of microRNA-122 biomarker in serum from patients with Drug-Induced Liver Injury
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
Objectives: This study aimed to assess the real use of cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis (IE) in the Spanish National Endocarditis Database (GAMES) and to compare it with antistaphylococcal penicillin (ASP). Methods: Prospective cohort study with retrospective analysis of a cohort of MSSA IE treated with cloxacillin and/or cefazolin. Outcomes assessed were relapse; intra-hospital, overall, and endocarditis-related mortality; and adverse events. Risk of renal toxicity with each treatment was evaluated separately. Results: We included 631 IE episodes caused by MSSA treated with cloxacillin and/or cefazolin. Antibiotic treatment was cloxacillin, cefazolin, or both in 537 (85%), 57 (9%), and 37 (6%) episodes, respectively. Patients treated with cefazolin had significantly higher rates of comorbidities (median Charlson Index 7, P <0.01) and previous renal failure (57.9%, P <0.01). Patients treated with cloxacillin presented higher rates of septic shock (25%, P = 0.033) and new-onset or worsening renal failure (47.3%, P = 0.024) with significantly higher rates of in-hospital mortality (38.5%, P = 0.017). One-year IE-related mortality and rate of relapses were similar between treatment groups. None of the treatments were identified as risk or protective factors. Conclusion: Our results suggest that cefazolin is a valuable option for the treatment of MSSA IE, without differences in 1-year mortality or relapses compared with cloxacillin, and might be considered equally effective